The Medical News

The Medical News

Glaucoma risk increased by air pollution To put these figures into perspective, the lifetime risk of developing schizophrenia is approximately two per cent, which equates to two out of a hundred people developing schizophrenia during their life. For people exposed to the lowest level of air pollution, the lifetime risk is just under two per cent, while the lifetime risk for those exposed to the highest level of air pollution is approx. three per cent. Unknown cause The results of the study have just been published in the scientific journal JAMA Network Open . "The risk of developing schizophrenia is also higher if you have a higher genetic liability for the disease. Our data shows that these associations are independent of each other. The association between air pollution and schizophrenia cannot be explained by a higher genetic liability in people who grow up in areas with high levels of air pollution," says Henriette Thisted Horsdal about the study, which is the first of its kind to combine air pollution and genetics in relation to the risk of developing schizophrenia. The study included 23,355 people in total, and of these, 3,531 developed schizophrenia. Though the results demonstrate an increased risk of schizophrenia when the level of air pollution during childhood increases, the researchers cannot comment on the cause. Instead they emphasise that further studies are needed before they can identify the cause of this association. Source: Aarhus University Journal reference: Horsdal, H. T. et al . (2019) Association of Childhood Exposure to Nitrogen Dioxide and Polygenic Risk Score for Schizophrenia With the Risk of Developing Schizophrenia. JAMA Network Open . doi.org/10.1001/jamanetworkopen.2019.14401



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More